semaglutide prediabetes progression to diabetes trial for Prediabetes: A Guide Preventing Type 2 GLP-1 Receptor Agonists as Treatments

Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications

While our bodies produce it constantly, our internal stores can be depleted by factors like environmental stress, poor nutrition, and physical trauma

Oral melanotic macule (MM) is a small, well-circumscribed, brown-to-black macule, and about of 665 cases has been reported in the English literature (2)

The satiety effect of GLP1-agonists reduces your food intake, appetite and hunger

Instead of a fast drop followed by quick regain, GLP-1 supports slower, more controlled changes that build over time

N Engl J Med 377:11191131